Related Experiment Video
Updated: May 23, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Long-term effect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease
Il Young Kim1, Soo Bong Lee, Dong Won Lee
1Division of Nephrology, Department of Internal Medicine, Pusan National University School of Medicine, Beomeo-ri, Mulgeum-eup, Yangsan, Gyeongsangnam-do 626-770, South Korea.
Insights
Intravenous contrast media in CT scans show no significant long-term impact on kidney function for chronic kidney disease (CKD) patients. This finding suggests contrast-enhanced CT is a safer imaging choice for CKD individuals compared to other methods.
Area of Science:
- Nephrology
- Radiology
- Medical Imaging
Background:
- Intravenous radiocontrast is known to pose a risk of acute kidney injury in chronic kidney disease (CKD) patients.
- However, the long-term renal effects of contrast media in CKD patients remain largely unknown.
Purpose of the Study:
- To investigate the long-term effects of intravenous radiocontrast used in computed tomography (CT) on renal function in patients with chronic kidney disease (CKD).
Main Methods:
- Retrospective review of 176 CKD patients (eGFR <60 ml/min/1.73 m2) who underwent contrast-enhanced CT.
- Patients were stratified into CKD stage 3 (n=104), CKD stage 4 (n=52), and peritoneal dialysis (PD, n=20) groups.
- Estimated glomerular filtration rates (eGFR) were monitored monthly for up to 8 months post-CT.
Main Results:
- No significant differences in baseline characteristics (age, sex, diabetes, follow-up duration) were observed between the groups.
- Overall, there were no significant changes in eGFR before and after CT across all patient groups.
- Subgroup analysis based on diabetes mellitus (DM) also showed no significant impact of CT contrast on eGFR.
Conclusions:
- Intravenous contrast media in standard CT scans do not appear to have significant long-term adverse effects on renal function in CKD patients, regardless of diabetes status.
- Contrast-enhanced CT may be a preferable imaging modality for CKD patients compared to gadolinium-based MRI, which carries a risk of nephrogenic systemic fibrosis.
Background:
The risk of acute kidney injury produced by intravenous radiocontrast in patients with chronic kidney disease (CKD) has been well known, but little is known about the long-term effects on renal function.
Methods:
We retrospectively reviewed the medical records of 176 CKD patients with estimated glomerular filtration rates (eGFR) <60 ml/min/1.73 m(2) who underwent computed tomography (CT) with intravenous radiocontrast at Pusan National University Hospital. Patients were divided into 3 groups (CKD stage 3, n = 104; CKD stage 4, n = 52; peritoneal dialysis, n = 20). Follow-up eGFR values were assessed on a monthly basis for up to 8 months.
Results:
In baseline characteristics, there were no significant differences between the 3 groups (i.e., CKD stage 3, stage 4, and PD) in the variables of age, sex, presence of diabetes and follow-up period. There were no significant differences between eGFR before and after CT in all patients and each of the 3 investigated groups. In each group, data analysis according to the presence of diabetes mellitus (DM) did not show significant differences of eGFR before and after CT.
Conclusion:
Overall, these results illustrate that intravenous contrast media used in the standard CT scan have no significant long-term effects on renal function in CKD patients, irrespective of DM. Therefore, from a long-term perspective, contrast-enhanced CT might be a better option than gadolinium-based magnetic resonance imaging, which is known to be associated with fatal nephrogenic systemic fibrosis in CKD patients.
Related Concept Videos
Imaging Studies III: Computed Tomography
Radiological Investigation I: X-ray and CT
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies for Cardiovascular System V: CT
Acute Kidney Injury III: Clinical Manifestations

